New HIV prevention approaches: promise, praxis, and pitfalls
- PMID: 35871803
- DOI: 10.1016/S0140-6736(22)01351-4
New HIV prevention approaches: promise, praxis, and pitfalls
Conflict of interest statement
KHM has received research grant funding from Gilead Sciences and Merck and has served on scientific advisory boards for Gilead Sciences, Merck, and ViiV Healthcare. BG has received consulting payments from Janssen; honoraria from Janssen, Merck, and GSK; and has received equipment, materials, or drugs from Gilead. All other authors declare no competing interests.
Comment on
-
Recent progress in broadly neutralizing antibodies to HIV.Nat Immunol. 2018 Nov;19(11):1179-1188. doi: 10.1038/s41590-018-0235-7. Epub 2018 Oct 17. Nat Immunol. 2018. PMID: 30333615 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
